These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7515169)

  • 1. Interferons for the treatment of hematological malignancies.
    Urabe A
    Oncology; 1994; 51(2):137-41. PubMed ID: 7515169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic effect of interferon on primary malignant tumour cells. Studies in various malignancies.
    Grandér D; Xu B; Einhorn S
    Eur J Cancer; 1993; 29A(14):1940-3. PubMed ID: 7506559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of interferons in the treatment of hematologic malignancies.
    Gutterman JU
    Semin Hematol; 1988 Jul; 25(3 Suppl 3):3-8. PubMed ID: 2459780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Interferon in hematological malignancies.
    Giles FJ; Ozer H
    Curr Opin Biotechnol; 1991 Dec; 2(6):847-50. PubMed ID: 1367959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia.
    Talpaz M; Kantarjian H; Kurzrock R; Gutterman JU
    Cancer; 1992 Jan; 69(2):410-2. PubMed ID: 1370212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferons. Treatment of malignant hemopathies with interferons].
    Guilhot F; Sadoun A; Delwail V
    Ann Med Interne (Paris); 1993; 144(8):548-56. PubMed ID: 7513980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon therapy for chronic myelogenous leukemia].
    Shibata A; Hashimoto S
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):200-6. PubMed ID: 8434957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferons in the treatment of hematological diseases].
    Jantunen E; Nousiainen T
    Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent advancements in the treatment of chronic myelogenous leukemia.
    O'Dwyer ME; Mauro MJ; Druker BJ
    Annu Rev Med; 2002; 53():369-81. PubMed ID: 11818480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of 2'-5' oligoadenylate synthetase during interferon treatment of chronic myelogenous leukemia.
    Moritz T; Weissmann B; Grünewald B; Hust H; Kummer G; Niederle N
    Mol Biother; 1992 Jun; 4(2):97-102. PubMed ID: 1381190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Minimal residual disease in chronic myelogenous leukemia].
    Ogawa H
    Nihon Rinsho; 2001 Dec; 59(12):2348-52. PubMed ID: 11766337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of chronic myelogenous leukaemia with interferons.
    Talpaz M; Kurzrock R; Kantarjian H; Gutterman J
    Cancer Surv; 1989; 8(4):793-8. PubMed ID: 2701727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
    Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
    Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon and chronic myelogenous leukaemia.
    Lauta VM
    Med Oncol; 1995 Mar; 12(1):41-6. PubMed ID: 8542246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia.
    Inoue T; Tojo A; Tsuchimoto D; Okamoto S; Ogura H; Tani K; Ozawa K; Shibuya M; Asano S
    Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotherapy with interferon--1988.
    Figlin RA
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biological activity of the interferons in hematologic malignancies.
    Gutterman JU
    Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon therapy for lymphoproliferative disorders.
    Roth MS; Bunn PA; Foon KA
    Cancer Treat Res; 1988; 38():231-52. PubMed ID: 2484433
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic myelogenous leukemia].
    Urabe A
    Nihon Rinsho; 2006 Jul; 64(7):1286-90. PubMed ID: 16838646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.